LLY · 10-Q · 2026Q2 · Full report
Revenue Performance and Mix
ELI LILLY & Co · 2026-08-05 · Importance 69 · Surprise 64 · From source text
Revenue increased to $22,974 million in the second quarter and $42,773 million in the first six months of 2026, from $15,558 million and $28,286 million, respectively, in the comparable 2025 periods. Growth was driven primarily by higher volume from Mounjaro and Zepbound, partially offset by lower realized prices. U.S. revenue reached $14,413 million in the quarter and $26,532 million year to date, while outside-U.S. revenue reached $8,561 million and $16,241 million, respectively. Mounjaro and Zepbound represented 65% of six-month revenue, highlighting increased concentration in the incretin portfolio.
Key facts
- Revenue increases for the three and six months ended June 30, 2026 were driven primarily by increased volume, partially offset by lower realized prices; the increased volume and lower realized prices were primarily driven by Mounjaro and Zepbound. source
- Revenue for the three months ended June 30, 2026: $22,974 million, compared with $15,558 million for the three months ended June 30, 2025. source
- Revenue for the six months ended June 30, 2026: $42,773 million, compared with $28,286 million for the six months ended June 30, 2025. source
- Outside U.S. revenue for the three months ended June 30, 2026: $8,561 million, compared with $4,743 million for the three months ended June 30, 2025. source
- U.S. revenue for the three months ended June 30, 2026: $14,413 million, compared with $10,814 million for the three months ended June 30, 2025. source
- Net income for the six months ended June 30, 2026: $14,491 million, compared with $8,420 million for the six months ended June 30, 2025. source
- Net income for the three months ended June 30, 2026: $7,095 million, compared with $5,661 million for the three months ended June 30, 2025. source
- Earnings per share - diluted for the six months ended June 30, 2026: $16.19, compared with $9.35 for the six months ended June 30, 2025. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +63.1% | Revenue for the six months ended June 30, 2026: $42,773 million, compared with $28,286 million for the six months ended June 30, 2025. |
| revenue | positive | realized | +32.3% | Revenue for the three months ended June 30, 2026: $22,974 million, compared with $15,558 million for the three months ended June 30, 2025. |
| net_income | positive | realized | +26.4% | Net income for the six months ended June 30, 2026: $14,491 million, compared with $8,420 million for the six months ended June 30, 2025. |
| revenue | positive | realized | +16.6% | Outside U.S. revenue for the three months ended June 30, 2026: $8,561 million, compared with $4,743 million for the three months ended… |
| revenue | positive | realized | +15.7% | U.S. revenue for the three months ended June 30, 2026: $14,413 million, compared with $10,814 million for the three months ended June 30,… |
| net_income | positive | realized | +6.2% | Net income for the three months ended June 30, 2026: $7,095 million, compared with $5,661 million for the three months ended June 30, 2025. |
| net_income | positive | realized | — | Earnings per share - diluted for the six months ended June 30, 2026: $16.19, compared with $9.35 for the six months ended June 30, 2025. |